DAVENPORT & Co LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$72,000
-76.7%
12,200
+31.1%
0.00%
-50.0%
Q3 2021$309,000
-14.2%
9,3050.0%0.00%
-33.3%
Q2 2021$360,000
-19.6%
9,305
+0.2%
0.00%
-25.0%
Q1 2021$448,000
-7.2%
9,2850.0%0.00%
-20.0%
Q4 2020$483,000
+107.3%
9,285
+6.7%
0.01%
+66.7%
Q3 2020$233,000
+12.0%
8,700
-18.7%
0.00%0.0%
Q2 2020$208,00010,7000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders